The CTO share price from a long term charting perspective is at an important juncture.
I suggest you might want to have a look at a one year weekly high/low chart, then adjust to a two year weekly high/low chart and keep doing that until you get to a five year weekly high/low chart. Then you might want to look at a 10 year weekly high/low chart.
This will paint an interesting story.
CTO has provided quite clear gold production guidelines to the market indicating that the company is now in serious gold production ramp up mode.
Yet the market is clearly worried. Just look at the lowly CTO share price.
I am at a complete loss to understand why CTO does not now keep the market informed with monthly updates of gold production and cash costs.
Surely CTO wants to reassure the market and all shareholders that the gold production ramp up is on track and in doing so of course help the share price?
So why does CTO Management not do this?
- Forums
- ASX - By Stock
- for all the true believers ...
CTO
citigold corporation limited
Add to My Watchlist
0.00%
!
0.3¢

The CTO share price from a long term charting perspective is at...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $6.027K | 1.81M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 17581526 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 2759580 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 17581526 | 0.003 |
5 | 5333668 | 0.002 |
4 | 18400999 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 2759580 | 5 |
0.005 | 11606846 | 12 |
0.006 | 2132952 | 5 |
0.007 | 1714285 | 2 |
0.008 | 2000000 | 1 |
Last trade - 15.00pm 27/06/2025 (20 minute delay) ? |
Featured News
CTO (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online